CHU de Toulous Hopital Larre

Toulouse 30030

0 studies enrolling now · 1 studies all time

What they study most

HER2-mutant Non-Small Cell Lung Cancer

Studies at this site

• Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer — Completed